Asiaticoside for Treating Overweight and Obesity
Asiaticoside for Treating Overweight/Obesity
Recruiting
N/A
Interventional Study
Overweight , Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Other
Who this trial is looking for
This trial is looking for adults who are overweight or obese. If you join, you will take asiaticoside tablets and help researchers understand how well they work for weight management.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older.
- I have a body mass index (BMI) of 24.0-45.0 kg/m².
- I am able and willing to provide written consent.
You may not be able to join if
- I have active pulmonary tuberculosis.
- I have severe liver injury or severe kidney problems.
- I have had severe heart problems in the past 6 months.
- I have severe gastrointestinal disorders or had gastrointestinal surgery in the past year.
- I have conditions causing obesity, like Cushing's syndrome.
- I have taken other anti-obesity treatments recently.
- I smoke or have smoked regularly in the past 3 months.
- I have diabetes or take diabetes medications.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Centella asiatica is a traditional herbal medicine widely used in China and Southeast Asia for treating various conditions. Preclinical studies have shown that madecassic acid glycosides, including asiaticoside and madecassoside, can significantly reduce body weight gain, adipose tissue mass, and serum triglyceride levels in high-fat diet-induced obese mice. These compounds also improve hepatic st…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older, male or female.
* Overweight or obesity, defined as a body mass index (BMI) of 24.0-45.0 kg/m².
* Able and willing to provide written informed consent.
Exclusion Criteria:
* Active pulmonary tuberculosis, malignant tumors, human immunodeficienc…
Contacts